Výsledky vyhledávání - "Kazuhiro Ezawa"

Akademický článek

Study on autonomous braking control system based on motion prediction considering overtaking motion of cyclists

Autor: Kazuhiro EZAWA, Pongsathorn RAKSINCHAROENSAK, Yasuhiro AKAGI, Kenta MAEDA, Takao KOJIMA

Publikováno v: Nihon Kikai Gakkai ronbunshu, Vol 84, Iss 865, Pp 17-00557-17-00557 (2018)

This paper presents motion prediction model of cyclist based on potential field for a hazard-anticipatory collision avoidance braking system to enhance the collision avoidance performance and secure the smoothness of driving. The target situation is

Externí odkaz: https://doaj.org/article/0f95b7bbad8a411fa50578e971ccb67a

Zobrazit plný text záznamu

CYFRA 21 -1: An Indicator of Survival and Therapeutic Effect in Lung Cancer

Autor: Takeyuki Makimoto, Kazuhiro Ezawa, Satoshi Tsuchiya, Ryusei Saito, Hidehiko Nakano, Atsushi Takise, Masaki Mori, Shinichi Ishihara, Ichiro Naruse, Hideki Hoshino, Taisuke Nomoto, Naoto Fueki, Koichi Minato, Yoshikazu Takei

Publikováno v: Oncology. 54:43-47

CYFRA 21-1 is a new tumor marker using two different monoclonal antibodies which recognize the divergent epitope on the N- or C-terminal region of domain 2 of cytokeratin 19 fragment, respectively. In this study, we investigated the relationship betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1b4f289c0ec5bf9312335c13df7032c
https://doi.org/10.1159/000227660

Zobrazit plný text záznamu

Induction of apoptosis by ubenimex (Bestatin®) in human non-small-cell lung cancer cell lines

Autor: Koichi Minato, Kunio Dobashi, Kazuhiro Ezawa

Publikováno v: Biomedicine & Pharmacotherapy. 50:283-289

Summary We studied the direct anti-tumor effects of ubenimex on five human lung cancer cell lines; ABC-1, RERF-LC-OK, RERF-LC-MS (adenocarcinoma) and SQ-5, EBC-1 (squamous cell carcinoma). Ubenimex dose-dependently inhibited the growth of these cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0aa14ba8d2e28c5e5e4863936dc9a3
https://doi.org/10.1016/0753-3322(96)84827-x

Zobrazit plný text záznamu

A Phase II Study of 72-Hour Continuous Infusion Consisting of Cisplatin and 5-Fluorouracil for Treatment of Non-Small Cell Lung Cancer

Autor: Atsushi Takise, Satoshi Tsuchiya, Takeyuki Makimoto, Yoshikazu Takei, Ryusei Saito, Naoto Fueki, Masatomo Mori, Hidehiko Nakano, Hideki Hoshino, Taisuke Nomoto, Ichiro Naruse, Kazuhiro Ezawa, Koichi Minato, Shinichi Ishihara

Publikováno v: Oncology. 52:246-250

A combination chemotherapy consisting of a 72-hour continuous infusion of cisplatin (CDDP; 100 mg/m2/72 h) and 5-fluorouracil (5-FU; 3 g/m2/72 h) was conducted for inoperable non-small cell lung cancer (NSCLC). Sixty patients were accepted for this s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261fbeaba14d957a14579e5385261149
https://doi.org/10.1159/000227466

Zobrazit plný text záznamu

A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer

Autor: Kazuhiro Ezawa, Ryusei Saitoh, Naoto Fueki, Hidehiko Nakano, Taisuke Nomoto, Takeyuki Makimoto, Satoru Watanabe, Koichi Minato, Sin-ichi Ishihara, Masatomo Mori, Ichirou Naruse, Satoshi Tsuchiya, Atsushi Takise, Yoshikazu Takei

Publikováno v: American journal of clinical oncology. 20(1)

It is reported that the combination of cisplatin (CDDP) and carboplatin (CBDCA) is synergistic in vitro. The objective of this study was to evaluate the therapeutic effect and safety of the two platinum compounds in combination with etoposide in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4bed0620c4bc7acce25826283067d84
https://pubmed.ncbi.nlm.nih.gov/9020288

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání